ADIPOQ and Obesity: In patients with obesity or type 2 diabetes, plasma levels of HMW adiponectin are decreased [117, 118] and a reduction in HMW adiponectin levels, rather than total adiponectin levels, contributes to the aetiology of obesity-associated diseases [119].